Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-06-16 9:00 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | ARCH Venture Partners IX LLC ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
0 | $0 | 36,412,716 (Indirect) |
View |
Ownership |
2021-06-16 7:24 pm |
N/A 2029-04-22 |
Lyell Immunopharma Inc. | LYEL | Turner Heather D Chief General Counsel |
0 | $0 | 1,215,000 (Direct) |
View |
Ownership |
2021-06-16 7:23 pm |
N/A 2031-05-19 |
Lyell Immunopharma Inc. | LYEL | Seely Lynn Director |
0 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-06-16 7:22 pm |
N/A 2030-05-18 |
Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director |
0 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-06-16 7:21 pm |
N/A 2031-02-04 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
0 | $0 | 4,318,000 (Direct) |
View |
Ownership |
2021-06-16 7:20 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner |
0 | $0 | 36,412,716 (Indirect) |
View |
Ownership |
2021-06-16 7:19 pm |
N/A 2031-04-21 |
Lyell Immunopharma Inc. | LYEL | NABEL ELIZABETH G Director |
0 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-06-16 7:18 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Executive Chairman |
0 | $0 | 14,772,824 (Direct) |
View |
Ownership |
2021-06-16 7:16 pm |
N/A 2028-11-05 |
Lyell Immunopharma Inc. | LYEL | Homans Elizabeth Chief Executive Officer |
0 | $0 | 8,328,870 (Direct) |
View |
Ownership |
2021-06-16 7:15 pm |
N/A 2029-07-09 |
Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Technical Ops. Officer |
0 | $0 | 1,300,000 (Direct) |
View |
Ownership |
2021-06-16 7:14 pm |
N/A 2031-04-08 |
Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director |
0 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-06-16 7:12 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director |
0 | $0 | 4,709,844 (Direct) |
View |
Ownership |
2021-06-16 7:11 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director |
0 | $0 | 4,515,842 (Indirect) |
View |